They joined us !
Creation : Juin 2023
Employees : 3
Turnover : NA
Adress : Lyon
Activity (biotech/medtech/healthtech) : Biotech
Who ?
IMUNYS is dedicated to research and innovation in adjuvant and immunostimulators for vaccine formulations. IMUNYS specially focuses on the in depth immunology understanding for immunostimulatory compounds’ mechanisms of action and for the structure-to-function relations in the vaccine adjuvant design and its impact on the development of new formulations. IMUNYS is relying on highly skilled and dedicated team in the field of formulation design, immunology and immune assays.
We are open for collaboration on immunology field for veterinary and human health. We also provide high class immune services for Immune assay design for adjuvants and immunostimulators or vaccines evaluation through a versatile proposition of immune assays at proof-of-concept level .
Why ?
Lyonbiopôle brings together all the health and biotech players in the AURA region and is a great place for exchange, sharing and collaboration opportunities for a start-up. IMUNYS’ membership in the cluster is natural because its research activity on immunostimulant and adjuvant formulations of vaccines is part of an important theme in the region. IMUNYS will be a member attentive to possible synergies within Lyonbiopôle organization.
Stéphane ASCARATEIL
CEO